Tag Archive for: Mayor Jim Kenney

Posts

Iovance Biotherapeutics Celebrates Grand Opening of Iovance Cell Therapy Center (iCTC)

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), is celebrating the official opening of the Iovance Cell Therapy Center (iCTC). The iCTC, located at the Philadelphia Navy Yard, is the first centralized, scalable, state-of-the-art manufacturing facility dedicated to producing TIL cell therapies for patients with solid tumor cancers. The current capacity is expected to meet potential demand for thousands of patients per year with multiple types of cancers, including clinical trial patients and future commercial patients.

Frederick Vogt, Ph.D., J.D., Interim President and Chief Executive Officer of Iovance, stated, “Since Iovance was founded, we have been dedicated to advancing novel cell therapies for patients with solid tumor cancers. As the hub of cell and gene therapy and the home of leading hospitals and academic centers, Philadelphia became the city of choice for our internal manufacturing. A little over two years after breaking ground, iCTC is now one of the largest cell therapy manufacturing facilities in the world and may ultimately house hundreds of employees. We now have the capacity to supply broad access to TIL therapies for patients. I believe that the important ecosystem within Cellicon Valley will continue to contribute to our advancements to pioneer a new class of treatment for cancer.”

A ribbon cutting event celebrates the opening with special guests including Pennsylvania Governor Tom Wolf, Philadelphia Mayor Jim Kenney, and other government officials and collaborators within Cellicon Valley. Patients, caregivers, and patient advocacy organizations, including Melanoma Research Foundation (MRF), Melanoma Research Alliance (MRA) and the Society for Gynecological Oncology’s Foundation for Women’s Cancer cut the ribbon on behalf of everyone who is currently fighting cancer, and in memory of those who lost their battles with cancer.

Sumit Verna, Iovance iCTC site head, at the ribbon cutting ceremony. He is joined by Fred Vogt, Iovance CEO, Governor Tom Wolf, and Mayor Jim Kenney.

“The iCTC is a symbol of significant innovation and opportunity for the commonwealth as hundreds of new, high-paying jobs will ultimately be created at this facility,” said Governor Tom Wolf. “Iovance has already made a positive impact on the region and worked with a great sense of urgency to complete construction and begin initial manufacturing for patients with cancer.”

“The iCTC represents a new model in cell therapy manufacturing and bolsters Philadelphia’s reputation as a leading location for technology, innovation, and life sciences,” said City of Philadelphia Mayor Jim Kenney. “Iovance is a great example of what companies from around the country and the world may accomplish in establishing Philadelphia as the place to attract talent and grow their business.”

Located at 300 Rouse Boulevard and with approximately 136,000 square feet of space, the iCTC is among the largest cell therapy manufacturing facilities today. The iCTC is currently supplying Iovance clinical studies, and commercial manufacturing is expected to begin after initial product approval. The iCTC was developed and built by Gattuso Development Partners, LLC and the design and construction management firm CRB. Financial incentives were provided by the Commonwealth of Pennsylvania, the City of Philadelphia, and PIDC, including the site’s designation as a Keystone Opportunity Improvement Zone, which allows incentives for business development.

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient’s own immune cells to attack cancer. TIL cells are extracted from a patient’s own tumor tissue, expanded through a proprietary process, and infused back into the patient. Upon infusion, TIL reach tumor tissue, where they attack cancer cells. The company has completed dosing in pivotal programs in patients with metastatic melanoma and cervical cancer. In addition, the company’s TIL therapy is being investigated in a registration-supporting study for the treatment of patients with locally advanced, recurrent or metastatic non-small cell lung cancer. Clinical studies are also underway to evaluate TIL in earlier stage cancers in combination with currently approved treatments, and to investigate Iovance peripheral blood lymphocyte (PBL) T cell therapy for blood cancers. For more information, please visit www.iovance.com.

Forward-Looking Statements

Certain matters discussed in this press release are “forward-looking statements” of Iovance Biotherapeutics, Inc. (hereinafter referred to as the “Company,” “we,” “us,” or “our”) within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). All such written or oral statements made in this press release, other than statements of historical fact, are forward-looking statements and are intended to be covered by the safe harbor for forward-looking statements provided by the PSLRA. Without limiting the foregoing, we may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “forecast,” “guidance,” “outlook,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, many of which are outside of our control, that may cause actual results, levels of activity, performance, achievements and developments to be materially different from those expressed in or implied by these forward-looking statements. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled “Risk Factors” in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and include, but are not limited to, the following substantial known and unknown risks and uncertainties inherent in our business: the effects of the COVID-19 pandemic; risks related to the timing of and our ability to successfully develop, submit, obtain and maintain U.S. Food and Drug Administration (“FDA”) or other regulatory authority approval of, or other action with respect to, our product candidates, and our ability to successfully commercialize any product candidates for which we obtain FDA approval; preliminary and interim clinical results, which may include efficacy and safety results, from ongoing clinical trials or cohorts may not be reflected in the final analyses of our ongoing clinical trials or subgroups within these trials or in other prior trials or cohorts; the risk that enrollment may need to be adjusted for our trials and cohorts within those trials based on FDA and other regulatory agency input; the new version of the protocol which further defines the patient population to include more advanced patients in our cervical cancer trial may have an adverse effect on the results reported to date; the risk that we may be required to conduct additional clinical trials or modify ongoing or future clinical trials based on feedback from the FDA or other regulatory authorities; the risk that our interpretation of the results of our clinical trials or communications with the FDA may differ from the interpretation of such results or communications by the FDA; the acceptance by the market of our product candidates and their potential reimbursement by payors, if approved; our ability or inability to manufacture our therapies using third party manufacturers or our own facility may adversely affect our potential commercial launch; the results of clinical trials with collaborators using different manufacturing processes may not be reflected in our sponsored trials; the risk that unanticipated expenses may decrease our estimated cash balances and forecasts and increase our estimated capital requirements; and other factors, including general economic conditions and regulatory developments, not within our control.

CONTACTS

Iovance Biotherapeutics, Inc:
Sara Pellegrino, IRC
Vice President, Investor Relations & Public Relations
650-260-7120 ext. 264
Sara.Pellegrino@iovance.com

Solebury Trout:
Zara Lockshin
646.378.2960
zlockshin@soleburytrout.com

Michael Kennedy Dedicates Battery Storage Project at the Philadelphia Navy Yard

Citizens Energy Vice President Michael Kennedy today flipped the switch on a 6.4-megawatt Battery Energy Storage System (BESS) to provide power cost savings to the Philadelphia Navy Yard and beyond through green energy technology.

The nephew of Citizens Energy Chairman, and former Massachusetts Congressman Joseph P. Kennedy II, was joined by Philadelphia Mayor Jim Kenney and PIDC leadership in dedicating the innovative project at the Navy Yard. The 1,200-acre former military base has been redeveloped into a thriving mixed-use campus led by PIDC, Philadelphia’s public-private economic development corporation and master developer of the historic shipyard.

“Everyone at Citizens Energy is proud to be helping Philadelphia transition to a greener future with Battery Storage Technology,” said Kennedy, who heads up new business development for the Boston-based nonprofit. “This system will be the largest of its kind in the city, and allow the Philadelphia Navy Yard to make better use of renewable energy as well as save money for local business and residents.”

The 2,240-lithium ion battery system housed in the industrial portion of the campus will provide a cheaper source of energy for the business tenants of the Navy Yard through peak shaving technology when the demand and cost of power is highest throughout the day. At times when the price of energy is stable locally, the BESS will participate in the Pennsylvania-New Jersey-Maryland (PJM) Interconnection’s frequency regulation market to regulate power on the regional grid.

“Completion of this project by Citizens Energy and PIDC is a great achievement for our City and the Navy Yard,” stated Philadelphia Mayor Jim Kenney. “Philadelphia continues to be innovative by introducing new systems like this battery energy storage system which not only improves the quality of life for residents and businesses, but uses energy more efficiently, reduces our carbon footprint, and helps Philadelphia reach our clean energy vision goals.”

“PIDC is thrilled to partner with Citizens Energy to bring this battery storage to the Navy Yard,” said Kate McNamara, PIDC’s Senior Vice President, Navy Yard. “Not only does this battery energy storage system provide a reliable, cost-effective, innovative solution for ongoing energy requirements, but it is a great foundation to support significant future job growth as businesses continue to locate and grow within Philadelphia and at the Navy Yard.”

“We have an enormous responsibility to our community and to our planet to not only make clean choices, but to ensure those choices are available to everyone,” said former Citizens Energy Chairman Joseph P. Kennedy II, who founded Citizens Energy Corporation over 40 years ago to make life’s basic needs more affordable. “This project not only reduces the cost of electricity for the Navy Yard, but also plays a key role in our fight against climate change.”

The 14.8-megwatt hour system represents a cutting-edge partnership between nonprofits that will usher in a new era of energy infrastructure at the landmark site. Battery storage technology is imperative to ensuring the success of the renewable energy revolution because it has the capacity to make green power available for future use. Facilities connected to battery storage technology will have uninterrupted use of power during major local outages and facilitate resilient buildings and microgrids.

Built next door to a retired steam plant, the Navy Yard BESS is the latest project to join an array of Navy Yard innovative and sustainable technologies and drives Philadelphia towards a cleaner and greener future. The BESS also joins the ranks of industrial and shipbuilding companies, cell and gene therapy production facilities, and global businesses at the historic campus, all powered by one of the East Coast’s largest unregulated electric grids.

This is Citizens Energy’s second completed BESS, having just unveiled its first in Western Massachusetts. The Boston-based nonprofit will soon complete several microgrid projects in other parts of New England and currently has over 40 solar projects in its national portfolio.

Ensemble/Mosaic Launches a Bold, Systemic $2.6B Environmental, Social & Governance Commitment at the Navy Yard

Partnership has Committed $7.5 Million to 21 Certified Minority and Women, Design & Engineering Firms to Lift Off $1B Diversity, Equity & Inclusion Pledge

Ensemble Real Estate Investments and Mosaic Development Partners (Ensemble/Mosaic) today announced it has launched its ambitious Environmental, Social & Governance (ESG) program at the Philadelphia Navy Yard, the bedrock of its plan to develop 109 acres of the campus.

“We believe our $2.6B ESG initiative to be one of the most significant commitments by any developer for any development in our country,” said Kam Babaoff, Co-Founder and Chairman of Ensemble Real Estate Solutions & Investments. “And, as part of this ambitious plan, we are committing $1B to diversity, equity and inclusion (DEI) initiatives – again, likely the largest pledge ever in our industry. Dedication to ESG, and specifically the DEI principals within it, will drive lasting positive change in this city because it will be built by Philadelphians for Philadelphians.”

PIDC, Philadelphia’s public-private economic development corporation and master developer of the Navy Yard, and Ensemble/Mosaic are partnering on the 2022 Philadelphia Navy Yard Plan Update. Ensemble/Mosaic will invest the $2.6 billion of development in the 1200-acre campus over the next two decades. The venture anticipates breaking ground on its first buildings – among them 1201 Normandy Place – in the fourth quarter of 2021.

A cornerstone of this ESG program is the partnership’s Diversity, Equity and Inclusion (DEI) strategy.

“PIDC set the tone for DEI in their request for proposal, and we felt inspired to create a plan with great scope and depth,” said Leslie Smallwood-Lewis, Principal of Mosaic, a minority-owned business enterprise. “Our DEI commitment will provide meaningful equity and capacity-building contracting opportunities for minority, women, veteran and disabled-owned business enterprises (MWVDBE) over the next two decades and we are excited to help create lasting change.”

Ensemble/Mosaic began deploying this strategy in the initial phase of development through the hiring of 20 local and national MWVDBE design and engineering firms such as Moody Nolan – the largest African American architecture firm in the nation and the “2021 AIA Firm of the Year”, Kelly Maiello and Rodriguez Consulting. Those commitments, representing approximately 50% ($7.5M) of the total allocation for design, have been made since the partnership was awarded the development rights by PIDC less than four months ago.

ESG Criteria as the North Star

ESG is a set of criteria created by an organization to guide socially responsible decisions. It includes environmental sustainability, such as impact on climate change or carbon footprint, recycling and water management; social impact through diversity, equity and inclusion (DEI), and organizational values; and governance, including partnership diversity, the auditing of DEI initiatives and  representation on boards and committees.

“From the moment we committed to answering the request for proposal from PIDC, ESG has been our north star,” said Greg Reaves, Principal of Mosaic. “Every decision we make, from design to development to neighborhood creation is through the lens of our ESG strategy.”

After the naval base closure in 1996, the City of Philadelphia, PIDC and its partners envisioned the redevelopment of the space into a thriving mixed-use campus, restoring it as an economic engine for the city. Over the last two decades, the Navy Yard has successfully attracted 150 businesses employing more than 15,000 personnel to the site with new development planned to further its position as one of Philadelphia’s most unique business campuses and evolving neighborhoods.

Through its development agreement with PIDC, Ensemble/Mosaic will redevelop 109 acres  of land through renovation and ground-up construction. The 20-year project includes the creation of additional office, laboratories and clean spaces, retail, restaurants and hotels, and residential buildings, parks, greenways and amenities.

“The Navy Yard has reestablished itself as a successful platform for job creation with a focus on innovation, production, and sustainability, and I commend PIDC and Ensemble/Mosaic on their shared vision and alignment of goals, which will further spur equitable growth in Philadelphia,” said Philadelphia Mayor Jim Kenney. “This unparalleled commitment to ESG sets the new standard for socially responsible, inclusive development in Philadelphia while providing countless benefits for Philadelphians for years to come.”

Bringing Meaningful, Measurable Change

Ensemble and Mosaic formed a partnership with the objective of focusing on redeveloping the Navy Yard by creating opportunities for diverse participants in every aspect of development.

To illustrate, Babaoff and Reaves broke down some of the many ESG-focused programs in motion or development, with a particular focus on DEI, such as:

  • Minority, Women, Veteran and Disabled-Owned Businesses Enterprises will equitably participate in every phase of the development cycle (design, construction and operations) at some of the highest levels ever achieved for a project of this size and scale. (See chart)
  • Minority Equity Investment ensures up-to-20% of the equity investment will be provided by minorities and minority-owned firms.
  • A Community Investment Platform will offer the opportunity for local low-and-moderate-income individuals to invest, through crowdfunding, collectively up to 5% of the equity in each project.
  • A Charitable Foundation, initially funded by a $1M commitment by Ensemble/Mosaic with continued funding from a percentage of the project’s net cash flow, will actively support and promote the development and economic empowerment of minorities and women.
  • An ongoing commitment to providing Housing Affordability for 15% of all residential units.
  • A minimum of a 35% Diverse Workforce during the construction of buildings with minority, female, veteran and disabled workforce.
  • A commitment to a minimum of 50% Local Workforce during construction from the Greater Philadelphia region.
  • MWVDBE Retail Opportunities by providing a minimum of 25% of all retail to firms with subsidized lease terms.
  • Internship program with local universities will bring opportunities to minority and female students in the Delaware Valley.

“The Navy Yard continues to be an economic engine for our region, and we are now focused on creating even more meaningful change. Ensemble/Mosaic is dedicating tremendous energy, time and financial commitment with its investment directed toward minority, women, disabled and veteran-owned companies,” said Councilmember Kenyatta Johnson, who represents the Navy Yard within the Second District. “This $1B pledge and each individual commitment will make an enormous difference to companies and individuals over the next 20 years.”

Pushing the Boundaries of Sustainability

“There is a long history of leadership around sustainability at the Philadelphia Navy Yard – from pilot programs for stormwater and autonomous shuttles to an 8MW peak-shaving battery back-up and Pennsylvania’s first community solar project, just to name a few,” said Kate McNamara, PIDC’s Senior Vice President, Navy Yard. “The campus already contains more than a dozen LEED certified buildings ranging from Certified to Double Platinum, and Ensemble/Mosaic’s commitment to sustainable development and management will continue to set the pace in our region and across the nation.”

Each Ensemble/Mosaic development project will be designed to achieve a LEED Silver or higher standard, demonstrably saving energy, water and other natural resources for the city and its residents. To carry these goals further, Ensemble/Mosaic has assembled a team of progressive design leaders, placemaking idea generators, and transportation futurists to create Philadelphia’s first LEED Certified Neighborhood Development at the Navy Yard.

LEED Neighborhood (LEED-ND) Development is a program engineered to inspire and help create better, more sustainable, well-connected neighborhoods, looking beyond the scale of buildings to consider entire communities. The Navy Yard will be one of the first of its kind designed with this new approach.

“One of the first things that really struck us as we went through the selection process for a development partner was Ensemble/Mosaic’s shared passion for the creation of an intentional and inclusive economic opportunity initiatives plan,” added McNamara. “We are excited that Ensemble/Mosaic quickly launched this plan concurrent with its development projects. This fresh approach will support the Navy Yard’s growth and positively impact generations of Philadelphia residents and businesses.”

 

Appendix 1: List of 21 MWVDBE Firms (alphabetized)

These firms are currently participating and are included in the $7.5M commitments in process.

 

Appendix 2: MWBE Representation Chart

PIDC Selects Navy Yard Development Partner

Renderings available HERE.

PIDC, Philadelphia’s public-private economic development corporation, has selected a team comprised of Ensemble Real Estate Investments and Mosaic Development Partners as its development partner for 109 acres at the Philadelphia Navy Yard. Selection of the Ensemble/Mosaic team is the culmination of a year-long competitive process that attracted interest from more than 35 development teams from across the country. The next phase of development will further establish the Navy Yard as a world-class business, manufacturing, R&D, and life sciences hub, and will include the creation of a vibrant mixed-use district including retail and makerspace. PIDC and the Ensemble/Mosaic team envision up to $2.6 billion of new private investment that will drive many thousands of new construction and permanent jobs.

Combined, the Ensemble/Mosaic team has successfully developed five million square feet of commercial, industrial, residential, and mixed-use properties in Philadelphia and across the country, and has been recognized for their exceptional projects and positive impacts to neighborhoods and communities. The team demonstrated an understanding of PIDC’s mission and shared a strategic vision for the Navy Yard to drive business growth and job creation for Philadelphia. The team also brings a deep commitment to diversity, equity, and inclusion at all levels of the project, including ownership, construction, professional services, operations, and tenancy. These factors, combined with the team’s local presence and experience, demonstrated financial capacity, and a track record of success with both new construction and adaptive re-use of historic buildings, positioned the Ensemble/Mosaic team as the clear choice to lead the next stage of growth and development at the Navy Yard.

New Mustin District will be focused on life sciences, commercial, office, and residential. Buildings are organized around pockets of green space and public recreation trails. Credit: DIGSAU

“Today’s announcement marks a significant milestone for this long-term public-private partnership led by PIDC that has brought the Navy Yard from the uncertainty and job losses of the early 1990’s to a dynamic home to more than 175 companies and 15,000 employees,” said Philadelphia Mayor Jim Kenney. “The Navy Yard has fulfilled its initial promise of becoming a thriving center for business, innovation, investment, talent, and jobs, establishing itself as one of the city’s major engines of economic growth. The exciting new partnership with Ensemble/Mosaic will not only build on this track record, but will also bring new ideas and energy to the Navy Yard while ensuring that equity and inclusion are at the forefront of its next phase of development.”

In alignment with PIDC’s commitment to diversity, equity, and inclusion, the Ensemble/Mosaic team is committed to providing opportunities for all Philadelphians to share in the next stage of successful development at the Navy Yard. This holistic inclusion strategy provides for minority- and women-owned business enterprise (M/WBE) participation, including diverse equity ownership with an innovative crowd-funding component, substantial M/WBE participation in construction and operations, inclusion of local and M/WBE small businesses in retail and makerspace opportunities, and allocating a share of net income to a charitable foundation that will create new opportunities for young people in Philadelphia.

“The long-term commitments and investments made by employers, developers, partners, and the U.S. Navy through the years has reestablished the Navy Yard as a major employment center in Philadelphia and as an exciting place to work,” said Kate McNamara, PIDC Senior Vice President, Navy Yard. “We are thrilled to embark on our new partnership with Ensemble and Mosaic to sustain and build on the Navy Yard’s momentum. Together, we will deliver on our commitment of an innovative, inclusive, and welcoming place in Philadelphia for workers to access jobs at all skill levels, businesses to grow and thrive, and visitors to appreciate the outdoors, public art, and history.”

New Mustin District will be focused on life sciences, commercial, office, and residential. Buildings are organized around pockets of green space and public recreation trails. Credit: DIGSAU

Ensemble, based locally at the Navy Yard and headquartered in Long Beach, California, is a full-service real estate solutions and investments provider that creates exceptional real estate in the healthcare, hospitality, commercial and urban multifamily/mixed-use sectors. Ensemble entered the Philadelphia market in 2012 when it began the development and construction of the 172-room Courtyard by Marriott hotel at the Navy Yard — and in 2016, its 40-room expansion. Since that time, Ensemble has developed, acquired, or is in development of 14 properties totaling 1.3 million square feet on over 45 acres at the Navy Yard, and is the largest private owner at the Navy Yard. Ensemble has successfully delivered over 4 million square feet across its national portfolio.

“We are excited to join together with PIDC and Mosaic to achieve our collective vision of providing high-quality mixed-use and residential projects, compelling public spaces, and a nationally recognized Life Sciences campus that the city of Philadelphia can be proud of,” said Kam Babaoff, Chairman of Ensemble Real Estate Investments. “We recognize the immense responsibility it will be to steward the development of the Navy Yard so it can endure for the good of the community for generations to come. Our partnership with Mosaic, with their intimate local perspective, keen development expertise, and innovative approaches to engaging every demographic in Philadelphia, heightens this perspective and will greatly contribute to a successful development.”

Mosaic Development Partners is a Philadelphia based, certified MBE real estate development and management company, founded in 2008 by Gregory Reaves and Leslie Smallwood-Lewis. Mosaic primarily focuses on ground up development and adaptive reuse of commercial properties in underserved urban communities. Since 2012, Mosaic and its partners have secured financing, invested, and initiated more than $200 million in the greater Philadelphia region, bringing quality retail, commercial, recreational, and residential space to communities of color, along with hundreds of construction and full-time jobs.

“The Mosaic team is thrilled to partner with Ensemble and PIDC on the next phase of the Navy Yard,” said Gregory Reaves, co-owner of Mosaic Development Partners. “The prior work at the Navy Yard has set an extremely high bar, and we are eager to apply our development model and expertise to bring unique perspective and solutions to the development team and create opportunities for disenfranchised businesses and communities who seek to become a part of this historic location.”

Redevelopment of historic Building 624: Historic Core pedestrian plaza flanked by artisan makerspaces for authentic local retail. Credit: Groundswell

In September 2019, PIDC put out a call for prospective partners through a Request for Qualifications (RFQ). PIDC received more than 35 responses to the RFQ in December 2019. Based on the RFQ criteria, five highly experienced teams were shortlisted and invited to submit full proposals in response to a comprehensive Request for Proposals (RFP). All five shortlisted teams submitted comprehensive proposals on May 22, 2020. After detailed review and evaluation of the proposals and virtual team interviews with an Advisory Panel, PIDC selected the Ensemble/Mosaic co-development team. The parties expect to finalize a development agreement shortly and pre-development work for the first project is expected to occur in 2021.

Redevelopment of historic Building 624: Historic Core pedestrian plaza flanked by artisan makerspaces for authentic local retail. Credit: Groundswell

 

Proposed residential building in the Historic Core with pedestrian plaza + ground floor retail for employees and residents. Credit: DIGSAU

About PIDC

PIDC is Philadelphia’s public-private economic development corporation. A non-profit founded in 1958 by the City of Philadelphia and the Greater Philadelphia Chamber of Commerce, PIDC’s mission is to spur investment, support business growth, and foster developments that create jobs, revitalize neighborhoods, and drive growth to every corner of Philadelphia. PIDC has invested more than $16.6 billion of financing and more than 3,200 acres of land sales—which has leveraged over $29 billion in total investment and assisted in retaining and creating hundreds of thousands of jobs in Philadelphia

For more information about PIDC, visit www.PIDCphila.com and follow us @PIDCphila on Twitter.

About the Navy Yard:

Today, the Navy Yard is a growing community of nearly 15,000 employees and 170 employers who occupy 7.5 million square feet across a mix of property types, including office, retail, industrial, R&D, and institutional. These employers include the Urban Outfitters headquarters; GSK’s North American headquarters; Jefferson Health; life science and technology startups; manufacturers; corporate R&D, including Axalta’s Global Innovation Center; critical U.S. Navy engineering centers; and a graduate engineering, business, and research campus for Penn State University.

In addition to its proximity to a large, diverse talent pool; airport and highway access; and the ability to create customizable workplaces, the Navy Yard offers community members a range of amenities including restaurants and cafes, a riverfront greenway, free shuttle access, bikeshare, and over 20 acres of open green space. The Navy Yard is a collaborative community with curated food trucks, health and wellness programs, rotating public art installations by local and international artists, and hosts a variety of food, fitness, and philanthropic events in its parks.

For more information about the Navy Yard, visit www.navyyard.org and follow us on Twitter @NavyYardPhila.

About Ensemble Real Estate Investments:

Over the past 40 years, Ensemble has successfully invested and developed over $2 billion in real estate across the United States, offering state-of-the-art property solutions in the healthcare, hospitality, commercial, and urban multi-family and mixed-use sectors. A widely respected leader in its industry, Ensemble has revolutionized the art of master planning, delivering iconic and strategically engineered facilities and beautifully preserved historic buildings—all designed to transform and inspire the communities they serve.

In January 2020, Ensemble opened its Philadelphia’s Navy Yard office, which will be led by previous Liberty Property Trust executives Brian Cohen and Mark Seltzer. The office seeks to support Ensemble’s East Coast growth, particularly at the Navy Yard where Ensemble has already invested $360 million. The company’s 14 Navy Yard properties boast a collective 1.3 million square feet and 45 acres, and include hotels, mixed-use developments, and life science facilities for leading-edge companies like Iovance Biotherapeutics, Adaptimmune, and WuXi Advanced Therapies.

To learn more about Ensemble, visit https://ensemble.net/.

About Mosaic Development Partners and Mosaic Brokerage Group:

Mosaic Development Partners is a Philadelphia based, minority certified commercial real estate development and project management company founded in 2008. Mosaic primarily focuses on ground up development and adaptive reuse of commercial properties in underserved urban communities. The company has successfully used viable, but complicated finance instruments (largely in the form of local, state, and federal loans and tax credits) to help stabilize and grow neighborhoods and create jobs. By partnering with municipalities, established developers, not-for-profit organizations and government entities, Mosaic has leveraged its investments and revitalized properties in struggling or stagnated communities. Since 2012, Mosaic and its partners have secured and invested more than $100 million in Philadelphia neighborhoods, resulting in hundreds of construction and full-time jobs, eliminating blight, and spurring additional investment in those communities.

Mosaic Brokerage Group (MBG) is a full-service real estate brokerage. Its agents are experienced in residential and commercial leasing and sales, tenant representation and the repositioning of existing assets. The brokerage is well regarded for its ability to assist its clients in evaluating and implementing improvements that will best position the asset to ensure a positive outcome.

To learn more about Mosaic, visit www.mosaicdp.com and www.mosaicbrokerage.com.

FOR ENSEMBLE/MOSAIC BIOS & PROJECTS, CLICK HERE.

Iovance Biotherapeutics Announces New Facility at the Navy Yard to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it has entered into a lease agreement to build an approximately 136,000 square foot commercial-scale production facility at the Philadelphia Navy Yard for commercial and clinical production of autologous TIL products, including its candidate lifileucel. Read more

Indego Bike Share Announces Expansion to South Philadelphia

Indego bike share program announced today that it will grow this summer, adding at least eight more stations to the system. Early summer expansion will include station and bike availability at the Navy Yard with connections at AT&T Station and FDR Park. Additional stations will be installed throughout the summer to provide more dock and bike availability in high ridership areas.  Read more

Adaptimmune Cuts Ribbon on U.S. Headquarters at the Navy Yard in Philadelphia

Adaptimmune Therapeutics plc. (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced it will host a ribbon cutting ceremony this morning at 10:30am at the Navy Yard in Philadelphia to celebrate the opening of its newly constructed U.S. headquarters and base for clinical and manufacturing operations. Developed by Liberty Property Trust (NYSE: LPT) and Synterra Partners, and under advisement of CBRE’s Life Science Advisory and Project Management Group, Adaptimmune’s 47,400 square foot facility, located at 351 Rouse Boulevard will include a state-of-the-art cGMP manufacturing facility designed to support the Company’s clinical development objectives and the initial commercialization of novel engineered immunotherapies for cancer. Adaptimmune’s Navy Yard facility currently houses 91 employees; this number is expected to grow to 120 by the end of 2017.

Read more

Navy Yard

The Navy Yard is considered the most successful redevelopment of a former military facility in the country and today is a growing community where companies and their employees thrive. Future growth will support up to 10 million square feet of commercial and residential development.

COPYRIGHT © PIDC ALL RIGHTS RESERVED – DESIGNED BY LEVLANE